EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics

Jiaxin Li, Jianping Liu iD, Nan Wang, Keyi Zhang, Wen Zhang, Mengze Gao, Zhiguo Lu iD, Xiaoyuan Chen iD, Yan Li iD

Advanced Materials · 18.10.2026

DOI: 10.1002/adma.75408 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 18.10.2026. Verfasst von Jiaxin Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technolog…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Open Funding Project of the State Key Laboratory of Biochemical Engineering & Key Laboratory of Biopharmaceutical Preparation and Delivery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have transformed RNA therapeutics through their high delivery efficiency, scalable manufacturing, and favorable safety profiles, as demonstrated by COVID‐19 mRNA vaccines and clinically approved small interfering RNA (siRNA) therapeutics. However, extending RNA delivery beyond the liver to extrahepatic tissues, including the spleen, lungs, lymph nodes, brain, and tumors, remains challenging because of the intrinsic hepatotropism of conventional LNPs and their limited cell‐type specificity. Recent advances in lipid chemistry, particle engineering, surface functionalization, protein corona modulation, and route‐specific administration have enabled new strategies to redirect LNPs toward specific tissues and cell populations. This review systematically examines these approaches and highlights key determinants of LNP tropism, including formulation composition, surface properties, endogenous protein adsorption, and administration route. We further discuss the clinical translation of extrahepatic LNP delivery, covering clinically validated products, emerging therapeutic candidates, and gaps between preclinical models and human applications. Major challenges include cell‐resolved biodistribution, long‐term safety, repeated‐dose immunogenicity, cross‐study comparability, and standardized quantitative assessment. Finally, we explore how high‐throughput screening, machine learning, and data‐driven design can accelerate the rational optimization of next‐generation LNPs. These advances may facilitate precise tissue‐ and cell‐selective RNA delivery, expanding the therapeutic potential of RNA medicines beyond the liver.

Schlagwörter

Stichwörter der Autor:innen

RNA therapeuticscell targetingextrahepatic deliverylipid nanoparticlesprotein corona

Autor:innen und Institutionen

  • Beijing Key Laboratory for Bioengineering and Sensing Technology, School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing, P. R. China.
  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, P. R. China.
  • Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Jinan, P. R. China.

ORCID-Profile: Jianping Liu, Zhiguo Lu, Xiaoyuan Chen, Yan Li

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Open Funding Project of the State Key Laboratory of Biochemical Engineering & Key Laboratory of Biopharmaceutical Preparation and Delivery
  • Beijing Nova Program
  • National University of Singapore
  • National Research Foundation
  • Shandong Cancer Hospital

Zitieren

APA

Li, J., Liu, J., Wang, N., Zhang, K., Zhang, W., Gao, M., Lu, Z., Chen, X., & Li, Y. (2026). Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics. Advanced Materials. https://doi.org/10.1002/adma.75408

Vancouver

Li J, Liu J, Wang N, Zhang K, Zhang W, Gao M, et al. Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics. Advanced Materials. 2026. doi:10.1002/adma.75408

BibTeX
@article{Li2026,
  author = {Li, Jiaxin and Liu, Jianping and Wang, Nan and Zhang, Keyi and Zhang, Wen and Gao, Mengze and Lu, Zhiguo and Chen, Xiaoyuan and Li, Yan},
  title = {Emerging Lipid Nanoparticle Targeting Strategies for Extrahepatic Delivery of RNA Therapeutics},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.75408}
}
Kostenlos starten →